Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Ameris Bancorp
ABCB
$6B
| $2.32M | ﹤0.01% |
51,833
+10,183
| +24% | +$467K |
|
|
AGCB
1602
DELISTED
Altimeter Growth Corp 2
AGCB
| $2.31M | ﹤0.01% |
233,405
+5,933
| +3% | +$58.7K |
|
1603
Krystal Biotech
KRYS
$9.61B
| $2.31M | ﹤0.01% |
33,131
+31,925
| +2,647% | +$2.31M |
|
1604
PMV Pharmaceuticals
PMVP
$62.4M
| $2.31M | ﹤0.01% |
193,871
+71,120
| +58% | +$1.03M |
|
|
HTLF
1605
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.31M | ﹤0.01% |
53,233
+9,248
| +21% | +$410K |
|
1606
Acuity Brands
AYI
$10.4B
| $2.31M | ﹤0.01% |
14,634
-2,725
| -16% | -$461K |
|
1607
Global E Online
GLBE
$6.98B
| $2.3M | ﹤0.01% |
86,113
+79,323
| +1,168% | +$2.26M |
|
1608
Vericel Corp
VCEL
$2.37B
| $2.3M | ﹤0.01% |
99,294
+84,618
| +577% | +$2.31M |
|
|
IGTA
1609
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
| $2.3M | ﹤0.01% |
231,806
+16,605
| +8% | +$165K |
|
1610
QuidelOrtho
QDEL
$1.2B
| $2.3M | ﹤0.01% |
32,160
+8,637
| +37% | +$773K |
|
1611
Oxford Industries
OXM
$579M
| $2.3M | ﹤0.01% |
25,599
+2,986
| +13% | +$289K |
|
1612
Associated Banc-Corp
ASB
$5.99B
| $2.3M | ﹤0.01% |
114,454
+47,597
| +71% | +$957K |
|
1613
Rocket Companies
RKT
$39.9B
| $2.29M | ﹤0.01% |
363,057
+150,124
| +71% | +$1.3M |
|
1614
National Fuel Gas
NFG
$7.75B
| $2.29M | ﹤0.01% |
37,260
+24,258
| +187% | +$1.67M |
|
|
HOUS
1615
DELISTED
Anywhere Real Estate
HOUS
| $2.29M | ﹤0.01% |
282,457
-103,302
| -27% | -$1.06M |
|
1616
First American
FAF
$7.76B
| $2.29M | ﹤0.01% |
49,681
-148,521
| -75% | -$8.03M |
|
1617
Marqeta
MQ
$1.89B
| $2.29M | ﹤0.01% |
80,326
+12,817
| +19% | +$427K |
|
1618
Cousins Properties
CUZ
$5.09B
| $2.29M | ﹤0.01% |
97,941
+12,784
| +15% | +$361K |
|
|
PHIC
1619
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
| $2.28M | ﹤0.01% |
228,658
| – | – |
|
1620
Belden
BDC
$4.98B
| $2.27M | ﹤0.01% |
37,872
+905
| +2% | +$57.6K |
|
1621
Lantheus
LNTH
$6.58B
| $2.27M | ﹤0.01% |
32,278
+9,632
| +43% | +$730K |
|
|
UMPQ
1622
DELISTED
Umpqua Holdings Corp
UMPQ
| $2.27M | ﹤0.01% |
132,780
-73,951
| -36% | -$1.31M |
|
1623
Coca-Cola Femsa
KOF
$22.8B
| $2.26M | ﹤0.01% |
38,754
+38,300
| +8,436% | +$2.28M |
|
|
ETNB
1624
DELISTED
89bio
ETNB
| $2.25M | ﹤0.01% |
388,982
+364,518
| +1,490% | +$1.6M |
|
|
ICPT
1625
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.25M | ﹤0.01% |
161,495
+125,752
| +352% | +$2.03M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.